CaRE2 Center Publication

Congratulations to our CaRE2 center for publishing a piece on our center’s structure, innovation, and initial outcomes. Read more here: https://ow.ly/QKVT50PVff2

Pink October – Breast Cancer Awareness Month

October is #BreastCancerAwarenessMonth! Learn about different risk factors and breast cancer screening guidelines. Consult your primary care physician and ask when the time is right to get screened. 🧬🔬🩻👨‍⚕️👩‍⚕️💗

Training Tuesday!

Congratulations to CaRE2 postbac, Steven Ewell, who is the recipient of the ABRCMS travel award and will be presenting his poster presentation on “In-Silico Identification of Oxa/thiazole Carboxamides as Potential Breast Cancer Therapeutic Agents with Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitory Effect.” 👏 #CaRE2HEC #ABRCMS #CancerResearch #TrainingTuesday

Indigenous People’s Day

CaRE2 celebrates Indigenous People’s Day! We recognize our CaRE2 members and their strides in research for Indigenous People. They have published 30+ research papers; a few can be found here. Great work!! We recognize: Drs. Scarton, Soto, Begay, Marconett, Webb, and Mason #IndigenousPeoplesDay #IndigenousPeoplesResearch #CaRE2HEC

National Liver Cancer Awareness Month

October is National Liver Cancer Awareness Month. Latinos suffer two times higher rates of liver cancer than their white peers (American Cancer Society). Join us in making a difference in cancer health disparities! 🎗 Octubre es el Mes Nacional de Concienciación sobre el Cáncer de Hígado. Los latinos padecen dos veces más de cáncer de […]

CaRE2 at AACR

CaRE2 enjoyed the AACR Cancer Health Disparities Conference in Orlando, FL! Our team was able to thrive in this environment as they networked, learned, and built new collaborations. Our PI was the conference co-chair, along with several other leaders as session chairs, planning committee, and presenting oral and poster presentations. We even had a whole […]

Congratulations Dr. Gbadamosi – $1.25 million grant

Congratulations to Dr. Gbadamosi on receiving the Early Independence Award from The National Institutes of Health Common Fund; he is 1 of 13 recipients. The award will provide Dr. Gbadamosi with up to $1.25 million over five years to establish his research program, entitled “Decoding the Heterogeneity in Chemo-Immunomodulation to Unlock the Potential of Chemoimmunotherapy […]

Trainees at AACR

Our CaRE2 trainees and early stage investigators had a great time at AACR! Several presented posters, had speaking engagements, and were session co-chairs. We are so proud of your efforts towards reducing cancer health disparities🎉👏